These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28316073)

  • 1. Arrhythmic effects of Epac-mediated ryanodine receptor activation in Langendorff-perfused murine hearts are associated with reduced conduction velocity.
    Li M; Hothi SS; Salvage SC; Jeevaratnam K; Grace AA; Huang CL
    Clin Exp Pharmacol Physiol; 2017 Jun; 44(6):686-692. PubMed ID: 28316073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epac-induced ryanodine receptor type 2 activation inhibits sodium currents in atrial and ventricular murine cardiomyocytes.
    Valli H; Ahmad S; Sriharan S; Dean LD; Grace AA; Jeevaratnam K; Matthews HR; Huang CL
    Clin Exp Pharmacol Physiol; 2018 Mar; 45(3):278-292. PubMed ID: 29027245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart.
    Hothi SS; Gurung IS; Heathcote JC; Zhang Y; Booth SW; Skepper JN; Grace AA; Huang CL
    Pflugers Arch; 2008 Nov; 457(2):253-70. PubMed ID: 18600344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RyR2-P2328S mutation downregulates Nav1.5 producing arrhythmic substrate in murine ventricles.
    Ning F; Luo L; Ahmad S; Valli H; Jeevaratnam K; Wang T; Guzadhur L; Yang D; Fraser JA; Huang CL; Ma A; Salvage SC
    Pflugers Arch; 2016 Apr; 468(4):655-65. PubMed ID: 26545784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conduction slowing contributes to spontaneous ventricular arrhythmias in intrinsically active murine RyR2-P2328S hearts.
    Zhang Y; Wu J; Jeevaratnam K; King JH; Guzadhur L; Ren X; Grace AA; Lei M; Huang CL; Fraser JA
    J Cardiovasc Electrophysiol; 2013 Feb; 24(2):210-8. PubMed ID: 23131176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flecainide exerts paradoxical effects on sodium currents and atrial arrhythmia in murine RyR2-P2328S hearts.
    Salvage SC; King JH; Chandrasekharan KH; Jafferji DI; Guzadhur L; Matthews HR; Huang CL; Fraser JA
    Acta Physiol (Oxf); 2015 Jul; 214(3):361-75. PubMed ID: 25850710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute atrial arrhythmogenicity and altered Ca(2+) homeostasis in murine RyR2-P2328S hearts.
    Zhang Y; Fraser JA; Jeevaratnam K; Hao X; Hothi SS; Grace AA; Lei M; Huang CL
    Cardiovasc Res; 2011 Mar; 89(4):794-804. PubMed ID: 20621925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial arrhythmia, triggering events and conduction abnormalities in isolated murine RyR2-P2328S hearts.
    King JH; Zhang Y; Lei M; Grace AA; Huang CL; Fraser JA
    Acta Physiol (Oxf); 2013 Feb; 207(2):308-23. PubMed ID: 22958452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological consequences of the P2328S mutation in the ryanodine receptor (RyR2) gene in genetically modified murine hearts.
    Goddard CA; Ghais NS; Zhang Y; Williams AJ; Colledge WH; Grace AA; Huang CL
    Acta Physiol (Oxf); 2008 Oct; 194(2):123-40. PubMed ID: 18419777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gap junction inhibition by heptanol increases ventricular arrhythmogenicity by reducing conduction velocity without affecting repolarization properties or myocardial refractoriness in Langendorff-perfused mouse hearts.
    Tse G; Yeo JM; Tse V; Kwan J; Sun B
    Mol Med Rep; 2016 Nov; 14(5):4069-4074. PubMed ID: 27633494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-arrhythmic atrial phenotypes in incrementally paced murine Pgc1β
    Valli H; Ahmad S; Fraser JA; Jeevaratnam K; Huang CL
    Exp Physiol; 2017 Dec; 102(12):1619-1634. PubMed ID: 28960529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
    Cerrone M; Noujaim SF; Tolkacheva EG; Talkachou A; O'Connell R; Berenfeld O; Anumonwo J; Pandit SV; Vikstrom K; Napolitano C; Priori SG; Jalife J
    Circ Res; 2007 Nov; 101(10):1039-48. PubMed ID: 17872467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular arrhythmogenesis following slowed conduction in heptanol-treated, Langendorff-perfused mouse hearts.
    Tse G; Hothi SS; Grace AA; Huang CL
    J Physiol Sci; 2012 Mar; 62(2):79-92. PubMed ID: 22219003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein expression profiles in murine ventricles modeling catecholaminergic polymorphic ventricular tachycardia: effects of genotype and sex.
    Saadeh K; Achercouk Z; Fazmin IT; Nantha Kumar N; Salvage SC; Edling CE; Huang CL; Jeevaratnam K
    Ann N Y Acad Sci; 2020 Oct; 1478(1):63-74. PubMed ID: 32713021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered re-excitation thresholds and conduction of extrasystolic action potentials contribute to arrhythmogenicity in murine models of long QT syndrome.
    Duehmke RM; Pearcey S; Stefaniak JD; Guzadhur L; Jeevaratnam K; Costopoulos C; Pedersen TH; Grace AA; Huang CL
    Acta Physiol (Oxf); 2012 Nov; 206(3):164-77. PubMed ID: 22510251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RyR2 inhibition with dantrolene is antiarrhythmic, prevents further pathological remodeling, and improves cardiac function in chronic ischemic heart disease.
    Schmeckpeper J; Kim K; George SA; Blackwell DJ; Brennan JA; Efimov IR; Knollmann BC
    J Mol Cell Cardiol; 2023 Aug; 181():67-78. PubMed ID: 37285929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ryanodine-receptor inhibition by dantrolene effectively suppresses ventricular arrhythmias in an ex vivo model of long-QT syndrome.
    Frommeyer G; Krawczyk J; Ellermann C; Bögeholz N; Kochhäuser S; Dechering DG; Fehr M; Eckardt L
    J Cardiovasc Electrophysiol; 2018 Mar; 29(3):471-476. PubMed ID: 29314443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of cardiac ryanodine receptor protects against stress-induced ventricular tachyarrhythmia, but increases the susceptibility to cardiac alternans.
    Zhong X; Vallmitjana A; Sun B; Xiao Z; Guo W; Wei J; Ni M; Chen Y; O'Brien ER; Gillis AM; Hoshijima M; Takeshima H; Hove-Madsen L; Benitez R; Belke D; Wayne Chen SR
    Biochem J; 2018 Jan; 475(1):169-183. PubMed ID: 29170159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmic substrate, slowed propagation and increased dispersion in conduction direction in the right ventricular outflow tract of murine Scn5a+/- hearts.
    Zhang Y; Guzadhur L; Jeevaratnam K; Salvage SC; Matthews GD; Lammers WJ; Lei M; Huang CL; Fraser JA
    Acta Physiol (Oxf); 2014 Aug; 211(4):559-73. PubMed ID: 24913289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of L-type Ca2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome 3.
    Thomas G; Gurung IS; Killeen MJ; Hakim P; Goddard CA; Mahaut-Smith MP; Colledge WH; Grace AA; Huang CL
    J Physiol; 2007 Jan; 578(Pt 1):85-97. PubMed ID: 17110414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.